Ignacio I. Wistuba, MD | Authors


Integrating Molecular Pathology Into NSCLC Treatment Selection

July 28, 2018

Ignacio I. Wistuba, MD, Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, discusses how clinicians can best integrate molecular pathology into their treatment selection for patients with non-small cell lung cancer.